Alexandria Real Estate Investors Can File Lawsuit by January 26, 2026
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: PRnewswire
- Lawsuit Notification: Kahn Swick & Foti reminds investors who purchased Alexandria Real Estate shares between January 27 and October 27, 2025, to file lead plaintiff applications by January 26, 2026, to participate in the securities class action lawsuit against the company.
- Financial Disclosure Issues: Alexandria's Q3 2025 financial results, disclosed on October 27, revealed lower occupancy rates and leasing activity, leading to a $323.9 million real estate impairment charge and a downward revision of full-year FFO guidance, causing a 19% drop in share price in just one day.
- Legal Accountability: The lawsuit alleges that Alexandria and certain executives failed to disclose material information during the class period, violating federal securities laws, which may result in significant economic losses for investors.
- Legal Consultation Access: Investors seeking to understand their legal rights or wishing to serve as lead plaintiffs can contact KSF through their hotline or website for more information, ensuring they act before the deadline to protect their interests.
Analyst Views on ARE
Wall Street analysts forecast ARE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARE is 64.78 USD with a low forecast of 30.00 USD and a high forecast of 104.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
2 Buy
9 Hold
1 Sell
Hold
Current: 57.260
Low
30.00
Averages
64.78
High
104.00
Current: 57.260
Low
30.00
Averages
64.78
High
104.00
About ARE
Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
